RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Quality of Life of Survivors of Thyroid Cancer Is Not Inferior to That in Subjects without Cancer: Long-Term after Over 5 Years

      한글로보기

      https://www.riss.kr/link?id=A108247745

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: Patients with thyroid cancer undergo less extensive surgery and additional therapies compared to those with othercancers. We aimed to compare the quality of life (QoL) between patients with thyroid cancer and healthy subjects using represe...

      Background: Patients with thyroid cancer undergo less extensive surgery and additional therapies compared to those with othercancers. We aimed to compare the quality of life (QoL) between patients with thyroid cancer and healthy subjects using representative data from Korea. Differences in QoL of thyroid cancer survivors according to the duration after cancer diagnosis was also evaluated.
      Methods: This population-based cohort study included 50,278 subjects who participated in the Korea National Health and NutritionExamination Survey between 2007 and 2017. QoL was compared between patients with thyroid cancer and healthy subjects usingself-reported data from the EuroQoL (EQ)-5 dimension (5D) and EQ-visual analog scale (VAS). Propensity score matching wasused to match thyroid cancer survivors to healthy subjects (1:5 matching).
      Results: Linear regression with univariate analysis showed that the presence of thyroid cancer was positively correlated with betterEQ-5D index scores (β-coefficient=0.010, P=0.046). After adjusting for multiple covariables, statistical significance was maintained. EQ-VAS fails to demonstrate any significant correlation. Among the EQ-5D categories, patients with thyroid cancer showedbetter self-care than healthy subjects. Thyroid cancer duration did not correlate with the EQ-5D index score. In subgroup analyses,compared to patients with thyroid cancer duration of <5 years, no significant difference was observed in the correlation between theEQ-5D index score and survival duration in those with thyroid cancer duration of 5 to 9 years and ≥10 years.
      Conclusion: Using a large-scale nationwide population-based database, our study demonstrated better QoL, especially in terms ofself-care, among thyroid cancer survivors than among healthy subjects without cancer.

      더보기

      참고문헌 (Reference)

      1 Watt T, "Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO" 162 : 161-167, 2010

      2 Bernardo DC, "Validity and reliability of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 : tagalog among adult filipinos with differentiated thyroid cancer" 33 : 174-180, 2018

      3 Gao YJ, "Thyroid tumor-initiating cells : increasing evidence and opportunities for anticancer therapy(review)" 31 : 1035-1042, 2014

      4 Massolt ET, "Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer" 85 : 781-788, 2016

      5 Megwalu UC, "Thyroid cancer incidence and mortality trends in the United States : 2000-2018" 32 : 560-570, 2022

      6 Filetti S, "Thyroid cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 30 : 1856-1883, 2019

      7 Yin DT, "The association between thyroid cancer and insulin resistance, metabolic syndrome and its components : a systematic review and meta-analysis" 57 : 66-75, 2018

      8 이가희, "The Revised 2016 Korean Thyroid Association Guidelines for Thyroid Nodules and Cancers: Differences from the 2015 American Thyroid Association Guidelines" 대한내분비학회 31 (31): 373-378, 2016

      9 Shakir MK, "Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma" 18 : 787-792, 2008

      10 Lee YK, "South Korean time trade-offvalues for EQ-5D health states : modeling with observed values for 101 health states" 12 : 1187-1193, 2009

      1 Watt T, "Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO" 162 : 161-167, 2010

      2 Bernardo DC, "Validity and reliability of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 : tagalog among adult filipinos with differentiated thyroid cancer" 33 : 174-180, 2018

      3 Gao YJ, "Thyroid tumor-initiating cells : increasing evidence and opportunities for anticancer therapy(review)" 31 : 1035-1042, 2014

      4 Massolt ET, "Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer" 85 : 781-788, 2016

      5 Megwalu UC, "Thyroid cancer incidence and mortality trends in the United States : 2000-2018" 32 : 560-570, 2022

      6 Filetti S, "Thyroid cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 30 : 1856-1883, 2019

      7 Yin DT, "The association between thyroid cancer and insulin resistance, metabolic syndrome and its components : a systematic review and meta-analysis" 57 : 66-75, 2018

      8 이가희, "The Revised 2016 Korean Thyroid Association Guidelines for Thyroid Nodules and Cancers: Differences from the 2015 American Thyroid Association Guidelines" 대한내분비학회 31 (31): 373-378, 2016

      9 Shakir MK, "Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma" 18 : 787-792, 2008

      10 Lee YK, "South Korean time trade-offvalues for EQ-5D health states : modeling with observed values for 101 health states" 12 : 1187-1193, 2009

      11 Dingle IF, "Salivary morbidity and quality of life following radioactive iodine for well-differentiated thyroid cancer" 148 : 746-752, 2013

      12 Howlader N, "SEER Cancer Statistics Review, 1975-2018" National Cancer Institute

      13 Park J, "Risk factors for cardiovascular disease among thyroid cancer survivors : findings from the Utah Cancer Survivors Study" 103 : 2468-2477, 2018

      14 Singer S, "Quality of life in patients with thyroid cancer compared with the general population" 22 : 117-124, 2012

      15 Crevenna R, "Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy" 11 : 597-603, 2003

      16 Eustatia-Rutten CF, "Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial" 64 : 284-291, 2006

      17 McIntyre C, "Quality of life in differentiated thyroid cancer" 50 : 133-136, 2018

      18 Hoftijzer HC, "Quality of life in cured patients with differentiated thyroid carcinoma" 93 : 200-203, 2008

      19 Borget I, "Quality of life and cost-effectiveness assessment of radioiodine ablation strategies in patients with thyroid cancer : results from the Randomized Phase III ESTIMABL Trial" 33 : 2885-2892, 2015

      20 Barbus E, "Psychological impact of 131I radioprotection measures on thyroid cancer patients" 91 : 441-447, 2018

      21 정규원 ; 원영주 ; 공현주 ; 이은숙, "Prediction of Cancer Incidence and Mortality in Korea, 2019" 대한암학회 51 (51): 431-437, 2019

      22 Huang SM, "Postoperative quality of life among patients with thyroid cancer" 47 : 492-499, 2004

      23 Jung MS, "Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma" 25 : 915-923, 2017

      24 Kurumety SK, "Post-thyroidectomy neck appearance and impact on quality of life in thyroid cancer survivors" 165 : 1217-1221, 2019

      25 Mitchell AL, "Management of thyroid cancer : United Kingdom National Multidisciplinary Guidelines" 130 (130): S150-S160, 2016

      26 Valle LA, "In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin" 23 : 185-193, 2013

      27 Hirsch D, "Illness perception in patients with differentiated epithelial cell thyroid cancer" 19 : 459-465, 2009

      28 Tagay S, "Health-related quality of life, depression and anxiety in thyroid cancer patients" 15 : 695-703, 2006

      29 Wang T, "Health-related quality of life of community thyroid cancer survivors in Hangzhou, China" 28 : 1013-1023, 2018

      30 Tan LG, "Health-related quality of life in thyroid cancer survivors" 117 : 507-510, 2007

      31 Nickel B, "Health-related quality of life after diagnosis and treatment of differentiated thyroid cancer and association with type of surgical treatment" 145 : 231-238, 2019

      32 Pickard AS, "Health utilities using the EQ-5D in studies of cancer" 25 : 365-384, 2007

      33 Schultz PN, "Health profiles and quality of life of 518 survivors of thyroid cancer" 25 : 349-356, 2003

      34 Maki Y, "Fatigue and quality of life among thyroid cancer survivors without persistent or recurrent disease" 11 : e210506-, 2022

      35 Lee JC, "Effect of thyroid-stimulating hormone suppression on muscle function after total thyroidectomy in patients with thyroid cancer" 12 : 769074-, 2021

      36 Pitoia F, "Dynamic risk assessment in patients with differentiated thyroid cancer" 26 : R553-R566, 2019

      37 Bongers PJ, "Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma" 167 : 94-101, 2020

      38 Husson O, "Development of a disease-specific health-related quality of life questionnaire(THYCA-QoL)for thyroid cancer survivors" 52 : 447-454, 2013

      39 Lee JI, "Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea" 8 : 101-, 2010

      40 Kim MH, "Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases" 14 : 1401-1406, 2005

      41 Lee JA, "Comparison of health-related quality of life between cancer survivors treated in designated cancer centers and the general public in Korea" 44 : 141-152, 2014

      42 Goswami S, "Clinical factors associated with worse quality-of-life scores in United States thyroid cancer survivors" 166 : 69-74, 2019

      43 Miller KD, "Cancer treatment and survivorship statistics, 2016" 66 : 271-289, 2016

      44 Blackburn BE, "Aging-related disease risks among young thyroid cancer survivors" 26 : 1695-1704, 2017

      45 Lee S, "A prospective comparison of patient body image after robotic thyroidectomy and conventional open thyroidectomy in patients with papillary thyroid carcinoma" 156 : 117-125, 2014

      46 Schroeder PR, "A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal" 91 : 878-884, 2006

      47 Mozzi A, "A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample" 8 : 267-274, 2016

      48 Giusti M, "A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma" 28 : 599-608, 2005

      49 Fugazzola L, "2019 European Thyroid Association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer" 8 : 227-245, 2019

      50 Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer" 26 : 1-133, 2016

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-12-16 학술지명변경 한글명 : 대한내분비학회지 -> Endocrinology and Metabolism
      외국어명 : Endocrinology and Metabolism -> 미등록
      KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-06-28 학술지명변경 외국어명 : Journal of Korean Endocrin Society -> Endocrinology and Metabolism KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-06-05 학회명변경 영문명 : The Korean Society Of Endocrinology -> Korean Endocrin Society KCI등재
      2007-06-01 학술지명변경 외국어명 : Journal of Korean Society of Endocrinology -> Journal of Korean Endocrin Society KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.23 0.23 0.26
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.22 0.508 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼